Hydroxyurea therapy requires HbF induction for clinical benefit in a sickle cell mouse model.
about
Whole exome sequencing identifies novel genes for fetal hemoglobin response to hydroxyurea in children with sickle cell anemiaHydroxyurea therapy of a murine model of sickle cell anemia inhibits the progression of pneumococcal disease by down-modulating E-selectinHydroxyurea and a cGMP-amplifying agent have immediate benefits on acute vaso-occlusive events in sickle cell disease miceHydroxyurea treatment inhibits proliferation of Cryptococcus neoformans in miceUpdate on fetal hemoglobin gene regulation in hemoglobinopathiesPharmacological Induction of Human Fetal Globin Gene in Hydroxyurea-Resistant Primary Adult Erythroid CellsInfluence of severity of anemia on clinical findings in infants with sickle cell anemia: analyses from the BABY HUG study.Hydroxyurea: Clinical and Hematological Effects in Patients With Sickle Cell Anemia.Hydroxyurea down-regulates BCL11A, KLF-1 and MYB through miRNA-mediated actions to induce γ-globin expression: implications for new therapeutic approaches of sickle cell diseaseA systematic review of known mechanisms of hydroxyurea-induced fetal hemoglobin for treatment of sickle cell diseaseOrganic anion transporting polypeptide 1B transporters modulate hydroxyurea pharmacokinetics.Emerging science of hydroxyurea therapy for pediatric sickle cell disease.Hydroxyurea therapy for sickle cell anemia.Opportunities for model-based precision dosing in the treatment of sickle cell anemia.Proteasome inhibition induces both antioxidant and hb f responses in sickle cell disease via the nrf2 pathway.Acute kidney injury during a pediatric sickle cell vaso-occlusive pain crisis.A Clinically Meaningful Fetal Hemoglobin Threshold for Children with Sickle Cell Anemia During Hydroxyurea Therapy.Clinical and Haematological Effects of Hydroxyurea in β-Thalassemia Intermedia Patients.Perfluorocarbon emulsion therapy attenuates pneumococcal infection in sickle cell mice.The rationale for using hydroxycarbamide in the treatment of sickle cell disease.Hydroxycarbamide alters erythroid gene expression in children with sickle cell anaemia.Acute Chest Syndrome in Children with Sickle Cell Disease.Quantification of HBG mRNA in primary erythroid cultures: prediction of the response to hydroxyurea in sickle cell and beta-thalassemia.
P2860
Q28544643-DBCAB839-1DB6-4E55-BDDD-7A629C2D3825Q30506249-2763A595-9C60-4199-9663-FE276FA60D2DQ30525565-375547E3-D615-409F-BA38-D4C80DC71003Q34287256-7524A1DD-5E7F-4F80-B9AA-60C05391E944Q34973945-1124FFB7-B7F7-4189-855C-B9A84C8BB5C1Q35634572-0FD03ACF-E291-4495-A0DD-3B8A843793D9Q35914597-A9BC96FB-0867-4006-865B-E3145E88AF77Q36718353-AC97634F-B06D-4BFD-99BA-6E6F9532B18AQ36777717-2C5DAB2A-0C82-4C7B-8B87-532BDD12FC92Q36792555-91BFF93A-A078-4808-90B0-CB2EA4EAA8FAQ37439697-D52A3B79-7FA5-4940-8C82-8981E8BC56EEQ38164192-2B355A4C-5087-4D1C-B02C-79D11423A2B6Q38586282-06B3EB10-468C-402F-B2D3-8E7457B212C2Q38642609-CC9C92B3-2A18-486F-835A-A4841B6B6909Q39011617-F64CFF89-3DB9-46AB-9387-6AAF213ADEC6Q39151267-E1729D35-DD3B-40A9-9CA1-4FE3AA993B49Q40038732-BD9D17F0-CDB4-43E5-B8D9-1388F4A29019Q40334323-387556BA-A904-41C5-A45D-B7444C6DAC91Q41646032-73EF9F54-5375-4FAB-BA60-3F140B3232D9Q42708637-E3861CF7-81B8-435B-80FC-BD1737167E33Q44416118-277981E5-E9F9-4DD3-B563-4FBBBE1A3E04Q47107252-46F2B3C4-665A-4540-A751-30C6B7444B62Q54791501-9150484B-2635-40B2-8794-FD5862B2EC49
P2860
Hydroxyurea therapy requires HbF induction for clinical benefit in a sickle cell mouse model.
description
2010 nî lūn-bûn
@nan
2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
name
Hydroxyurea therapy requires H ...... in a sickle cell mouse model.
@ast
Hydroxyurea therapy requires H ...... in a sickle cell mouse model.
@en
Hydroxyurea therapy requires H ...... in a sickle cell mouse model.
@nl
type
label
Hydroxyurea therapy requires H ...... in a sickle cell mouse model.
@ast
Hydroxyurea therapy requires H ...... in a sickle cell mouse model.
@en
Hydroxyurea therapy requires H ...... in a sickle cell mouse model.
@nl
prefLabel
Hydroxyurea therapy requires H ...... in a sickle cell mouse model.
@ast
Hydroxyurea therapy requires H ...... in a sickle cell mouse model.
@en
Hydroxyurea therapy requires H ...... in a sickle cell mouse model.
@nl
P2093
P2860
P1433
P1476
Hydroxyurea therapy requires H ...... in a sickle cell mouse model.
@en
P2093
Derek A Persons
Jeffrey D Lebensburger
Kelli L Boyd
Russell E Ware
Tamara I Pestina
P2860
P304
P356
10.3324/HAEMATOL.2010.023325
P577
2010-04-07T00:00:00Z